A rare case of Visceral leishmaniasis with multiple relapse and multi-drug unresponsive: successfully treated with combination therapy
Authors:
- 22 July 2011
- journal article
- case report
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 33 (5) , 726-729
Abstract
Case We report a 32-year old relapse case of Visceral leishmaniasis, treated with Paromomycin who belonged from a endemic zone of Bihar state, India. After confirmation, he was treated with Amphotericin B, followed by Liposomal Amphotericin B in full course and even in higher dose. But after each therapy, the patient either did not responded or relapsed after treatment. Ultimately, the patient was successfully treated with combination therapy of Liposomal amphotericin B and Miltefosine without any relapse. Conclusion The multi-drug unresponsive Visceral leishmaniasis cases could pose a major threat to treatment strategy in the elimination program. In such situation, combination therapy seems to be a better approach that needs to be explored.Keywords
This publication has 10 references indexed in Scilit:
- Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trialThe Lancet, 2011
- Ambisome plus miltefosine for Indian patients with kala-azarTransactions of the Royal Society of Tropical Medicine and Hygiene, 2011
- Leishmania commandeers the host inflammatory response through neutrophilsTrends in Parasitology, 2009
- Parasite Susceptibility to Amphotericin B in Failures of Treatment for Visceral Leishmaniasis in Patients Coinfected with HIV Type 1 andLeishmania infantumClinical Infectious Diseases, 2009
- The Relationship between Leishmaniasis and AIDS: the Second 10 YearsClinical Microbiology Reviews, 2008
- Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivoInternational Journal of Antimicrobial Agents, 2007
- Injectable Paromomycin for Visceral Leishmaniasis in IndiaNew England Journal of Medicine, 2007
- Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian EpidemicClinical Infectious Diseases, 2000
- Use of Amphotericin B in Drug-Resistant Cases of Visceral Leishmaniasis in North Bihar, IndiaThe American Journal of Tropical Medicine and Hygiene, 1995
- New Perspectives on a Subclinical Form of Visceral LeishmaniasisThe Journal of Infectious Diseases, 1986